The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V., Torchilin, V., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,920
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,378
Multidrug resistance (MDR) in cancer
Krishna, R., & Mayer, L. D. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00114-7 · Cited by 1,026
Nanoparticulate systems for brain delivery of drugs
Kreuter, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.015 · Cited by 958
Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies
Kartner, N., Evernden-Porelle, D., Bradley, G., & Ling, V. (1985) · Nature · doi:10.1038/316820a0 · Cited by 908
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
Stealth Me. PEG‐PLA Nanoparticles Avoid Uptake by the Mononuclear Phagocytes System
Bazile, D., Prud'homme, C., Bassoullet, M., Marlard, M., Spenlehauer, G., & Veillard, M. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840420 · Cited by 635
Design of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480
Couvreur, P., Kante, B., Roland, M., Guiot, P., Bauduin, P., & Speiser, P. (1979) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1979.tb13510.x · Cited by 452
Long-circulating pegylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery.
Calvo, P., Gouritin, B., Chacun, H., Desmaële, D., D'Angelo, J., Noel, J.-P., Georgin, D., Fattal, E., Andreux, J. P., & Couvreur, P. (2001) · Pharmaceutical Research · doi:10.1023/a:1010931127745 · Cited by 443
Peracchia, M. T., Fattal, E., Desmaële, D., Besnard, M., Noël, J. P., Gomis, J. M., Appel, M., d’Angelo, J., & Couvreur, P. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00063-2 · Cited by 400
Resistance mechanisms associated with altered intracellular distribution of anticancer agents
Larsen, A. K., Escargueil, A. E., & Skladanowski, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00073-x · Cited by 369
Pharmacokinetics and distribution of a biodegradable drug-carrier
Grislain, L., Couvreur, P., Lenaerts, V., Roland, M., Deprez-Decampeneere, D., & Speiser, P. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90166-7 · Cited by 305
Jain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298
Emilienne Soma, C., Dubernet, C., Bentolila, D., Benita, S., & Couvreur, P. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00125-8 · Cited by 281
Brigger, I., Morizet, J., Aubert, G., Chacun, H., Terrier-Lacombe, M.-J., Couvreur, P., & Vassal, G. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.039669 · Cited by 234
Olivier, J.-C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., & Couet, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018947208597 · Cited by 213
Gelperina, S. E., Khalansky, A. S., Skidan, I. N., Smirnova, Z. S., Bobruskin, A. I., Severin, S. E., Turowski, B., Zanella, F. E., & Kreuter, J. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00456-8 · Cited by 185
de Verdière, A., Dubernet, C., Némati, F., Soma, E., Appel, M., Ferté, J., Bernard, S., Puisieux, F., & Couvreur, P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.362 · Cited by 168
Calvo, P., Gouritin, B., Villarroya, H., Eclancher, F., Giannavola, C., Klein, C., Andreux, J. P., & Couvreur, P. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01967.x · Cited by 164
Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance
Cuvier, C., Roblot-Treupel, L., Millot, J. M., Lizard, G., Chevillard, S., Manfait, M., Couvreur, P., & Poupon, M. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90443-m · Cited by 156
Kattan, J. G., Droz, J., Couvreur, P., Marino, J. P., Boutan-Laroze, A., Rougier, P. R., Brault, P., Vranckx, H., Grognet, J., Morge, X., et al. (1992) · Investigational New Drugs · doi:10.1007/bf00877245 · Cited by 153
Tissue Distribution of Antitumor Drugs Associated with Polyalkylcyanoacrylate Nanoparticles
Couvreur, P., Kante, B., Lenaerts, V., Scailteur, V., Roland, M., & Speiser, P. P. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600690222 · Cited by 152
Juliano, R. L., Alahari, S. K., Yoo, H., Kole, R., & Cho, M. (1999) · Pharmaceutical Research · doi:10.1023/a:1011958726518 · Cited by 145
Bennis, S., Chapey, C., Robert, J., & Couvreur, P. (1994) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80025-5 · Cited by 142
Peracchia, M. T., Vauthier, C., Desmaële, D., Gulik, A., Dedieu, J., Demoy, M., d’Angelo, J., & Couvreur, P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011973625803 · Cited by 141
Self-citationChiannilkulchai, N., Ammoury, N., Caillou, B., Devissaguet, J. P., & Couvreur, P. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02897257 · Cited by 130
Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells
de Verdière, A. C., Dubernet, C., Némati, F., Poupon, M., Puisieux, F., & Couvreur, P. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686509 · Cited by 119
Lenaerts, V., Nagelkerke, J. F., van Berkel, T. J. C., Couvreur, P., Grislain, L., Roland, M., & Speiser, P. P. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600730730 · Cited by 116
Tissue distribution of doxorubicin associated with polyisohexylcyanoacrylate nanoparticles
Verdun, C., Brasseur, F., Vranckx, H., Couvreur, P., & Roland, M. (1990) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf02940287 · Cited by 115
Delivery systems for antisense oligonucleotides
GARCIA-CHAUMONT, C., Seksek, O., Grzybowska, J., Borowski, E., & Bolard, J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00062-0 · Cited by 103
Doxorubicin-Loaded Nanoparticles: Increased Efficiency in Murine Hepatic Metastases
Chiannilkulchai, N., Driouich, Z., Benoît, J., PARODI, A. L., & Couvreur, P. (1989) · Selective Cancer Therapeutics · doi:10.1089/sct.1989.5.1 · Cited by 102
Thierry, A. R., Rahman, A., & Dritschilo, A. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1142 · Cited by 96
Soma, C. E., Dubernet, C., BARRATT, G. M., Benita, S., & Couvreur, P. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00269-8 · Cited by 86
Sharma, D., Chelvi, T. P., Kaur, J., Chakravorty, K., De, T., Maitra, A. N., & Ralhan, R. (1996) · PubMed · Cited by 85
Clinical relevance of the molecular mechanisms of resistance to anti-cancer drugs
Brown, R. E., & Links, M. J. (1999) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399499001099x · Cited by 85
Soma, C. E., Dubernet, C., BARRATT, G. M., Némati, F., Appel, M., Benita, S., & Couvreur, P. (1999) · Pharmaceutical Research · doi:10.1023/a:1018902031370 · Cited by 78
PEGylated polycyanoacrylate nanoparticles as tumor necrosis factor-α carriers
Li, Y., Pei, Y., Zhou, Z.-H., Zhang, X., Gu, Z.-H., Ding, J., Zhou, J.-J., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00235-8 · Cited by 76
Némati, F. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04559-0 · Cited by 67
Targeting of drugs 6 : strategies for stealth therapeutic systems
Gregoriadis, G. C. (1998) · Plenum Press eBooks · Cited by 56
Li, Y., Pei, Y., Zhao-Hui, Z. H. O. U., Zhang, X., Gu, Z.-H., Ding, J., Zhou, J.-J., Xiu-Jian, G. A. O., & Zhu, J. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.662 · Cited by 41
Pepin, X. J. H., Attali, L., Domrault, C., Gallet, S., Métreau, J. M., Reault, Y., Cardot, P. J. P., Imalalen, M., Dubernet, C., Soma, C. E., et al. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00362-9 · Cited by 38
Rolland, A. P. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90330-x · Cited by 36
Roblot-Treupel, L., Poupon, M., Couvreur, P., & Puisieux, F. (1991) · PubMed · Cited by 7
Cited by
Biodegradable polymers as biomaterials
Nair, L. S., & Laurencin, C. T. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.017 · Cited by 4,416
Horcajada, P., Chalati, T., Serre, C., Gillet, B., Sebrie, C., Baati, T., Eubank, J. F., Heurtaux, D., Clayette, P., Kreuz, C., et al. (2010) · Nature Materials · doi:10.1038/nmat2608 · Cited by 4,260
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Metadata
- Authors
- Vauthier, C.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2003-12-05
- Volume
- 93
- Issue
- 2
- Pages
- 151-160
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2073579085
- Cited by
- 283
- References
- 51
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.